Roughly 4.5 million Americans are living with chronic liver disease and cirrhosis, and it ranks as the 11th leading cause of death in the United States, according to the CDC. Cirrhosis represents the end stage of virtually every chronic liver disease — a point where years of damage have replaced healthy liver tissue with scar tissue, compromising the organ’s ability to function. What makes cirrhosis particularly treacherous is that the liver compensates remarkably well for a long time, hiding the damage until a critical threshold is crossed. For a broader view of chronic conditions, see our medical conditions guide.
What Is Cirrhosis?
Cirrhosis is the advanced scarring (fibrosis) of the liver resulting from long-term liver damage. The liver is one of the most resilient organs in the body — it can regenerate, compensate for lost function, and tolerate substantial injury. But when that injury is chronic and ongoing, the regenerative process goes awry. Instead of healthy liver cells, the body lays down dense scar tissue that distorts the liver’s architecture and impedes blood flow through it.
This scarring has two major consequences. First, it reduces the liver’s functional capacity — its ability to process nutrients, produce proteins, detoxify the blood, and make bile. Second, it creates resistance to blood flow through the liver, raising pressure in the portal vein (portal hypertension) and triggering a cascade of life-threatening complications.
The NIDDK notes that cirrhosis is not a single disease but the final common pathway of many different liver diseases. The damage is generally considered irreversible at the cirrhotic stage, though treating the underlying cause can prevent further progression and, in some cases, allow modest improvement in liver function.
Causes
Alcohol-related liver disease has historically been the most recognized cause of cirrhosis. Heavy alcohol consumption over years causes inflammation (alcoholic hepatitis) and progressive fibrosis that can ultimately lead to cirrhosis. Not all heavy drinkers develop cirrhosis — genetic factors, nutrition, and co-existing liver conditions influence susceptibility. Generally, consuming more than two to three drinks per day for men and one to two for women over a prolonged period significantly increases risk.
Chronic hepatitis C was the second most common cause and a leading reason for liver transplantation for decades. The development of direct-acting antiviral medications that cure hepatitis C in over 95% of patients has been transformative — but many people with hepatitis C remain undiagnosed, and those already cirrhotic still face ongoing risks. Chronic hepatitis B causes cirrhosis primarily in regions where it is endemic, though antiviral treatment can prevent progression.
Nonalcoholic steatohepatitis (NASH) — the progressive form of fatty liver disease — is the fastest-growing cause of cirrhosis and is projected to become the leading indication for liver transplantation. NASH-related cirrhosis is driven by the same metabolic factors as type 2 diabetes and obesity. Other causes include autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, hemochromatosis (iron overload), Wilson’s disease (copper overload), and drug-induced liver injury. According to the Mayo Clinic, in some cases, the cause is never identified (cryptogenic cirrhosis).
Stages: Compensated vs. Decompensated
The clinical course of cirrhosis is divided into two broad stages that have dramatically different implications. Compensated cirrhosis means the liver, despite significant scarring, is still functioning well enough to perform its essential tasks. People with compensated cirrhosis may have no symptoms at all and can remain in this stage for years or even decades. The median survival for compensated cirrhosis is approximately 12 years or more.
Decompensated cirrhosis occurs when the liver can no longer compensate, and complications develop. The hallmark events marking decompensation include ascites (fluid accumulation in the abdomen), variceal bleeding (rupture of swollen veins in the esophagus or stomach), hepatic encephalopathy (confusion and altered mental status from toxin buildup), and jaundice (yellowing of the skin and eyes). Once decompensation occurs, median survival drops to approximately 2 years without transplantation.
The Model for End-Stage Liver Disease (MELD) score — based on bilirubin, creatinine, and INR (a measure of blood clotting) — is used to assess disease severity and prioritize patients for liver transplantation. Higher MELD scores indicate more severe liver disease and higher short-term mortality. The Cleveland Clinic uses the MELD score as a key tool in transplant decision-making.
Symptoms
In the compensated stage, symptoms are often absent or nonspecific: fatigue, weakness, mild appetite loss, or vague abdominal discomfort. These are easily attributed to other causes, which is why cirrhosis is frequently discovered during evaluation for something else entirely — an abnormal blood test, an imaging study, or a routine physical exam.
As the disease progresses to decompensation, symptoms become more pronounced and harder to ignore. Ascites causes visible abdominal swelling, discomfort, and difficulty breathing when severe. Jaundice turns the skin and whites of the eyes yellow. Easy bruising and bleeding occur because the liver can’t produce enough clotting factors. Hepatic encephalopathy causes confusion, personality changes, disorientation, and in severe cases, coma.
Other symptoms include intense itching (pruritus), spider-like blood vessels on the skin (spider angiomata), redness of the palms (palmar erythema), swelling of the legs, muscle wasting, enlargement of breast tissue in men (gynecomastia), dark urine, and pale stools. The NIDDK emphasizes that the appearance of any of these signs warrants urgent medical evaluation.
Diagnosis
Blood tests often provide the first clues: elevated liver enzymes (though these may be normal in advanced cirrhosis), low albumin, elevated bilirubin, prolonged INR, and low platelet count (thrombocytopenia, caused by portal hypertension and splenic enlargement). A comprehensive metabolic panel and complete blood count are standard initial tests.
Imaging with ultrasound, CT scan, or MRI can reveal a nodular, shrunken liver, enlarged spleen, ascites, and dilated portal vein — all indicators of cirrhosis and portal hypertension. Transient elastography (FibroScan) measures liver stiffness non-invasively and can quantify the degree of fibrosis, sometimes detecting advanced fibrosis before clinical cirrhosis is apparent.
Liver biopsy remains the gold standard for confirming cirrhosis, determining the underlying cause, and assessing the degree of inflammation and fibrosis. However, it’s not always necessary when clinical, laboratory, and imaging findings are unambiguous. Upper endoscopy is performed to screen for esophageal and gastric varices — dilated veins that can bleed catastrophically — and should be done in all patients with newly diagnosed cirrhosis.
Complications and Their Management
Portal Hypertension and Varices
Scar tissue blocks normal blood flow through the liver, increasing pressure in the portal venous system. This forces blood to find alternative routes, creating swollen, fragile veins (varices) in the esophagus, stomach, and rectum. Variceal bleeding is a life-threatening emergency — roughly 20-30% of patients die during the first bleeding episode. Non-selective beta-blockers (propranolol, nadolol) and endoscopic band ligation reduce the risk of first and recurrent variceal bleeding.
Ascites
Ascites — fluid accumulation in the abdominal cavity — is the most common complication of cirrhosis. It’s managed with sodium restriction (less than 2,000 mg daily) and diuretics (spironolactone with or without furosemide). When ascites is severe or refractory to medication, large-volume paracentesis (draining the fluid with a needle) provides symptomatic relief. Spontaneous bacterial peritonitis (SBP) — infection of ascitic fluid — is a serious complication requiring prompt antibiotic treatment and prophylaxis.
Hepatic Encephalopathy
When the liver fails to clear toxins — particularly ammonia — from the blood, they reach the brain and cause cognitive dysfunction ranging from subtle concentration difficulties to coma. Treatment includes lactulose (which promotes ammonia excretion through the bowel) and rifaximin (an antibiotic that reduces ammonia-producing bacteria in the gut). The Mayo Clinic notes that hepatic encephalopathy is often reversible with treatment.
Hepatocellular Carcinoma
Cirrhosis from any cause significantly increases the risk of liver cancer (hepatocellular carcinoma, or HCC). Surveillance with ultrasound and alpha-fetoprotein (AFP) blood test every six months is recommended for all patients with cirrhosis. Early detection of HCC allows for potentially curative treatments including surgical resection, ablation, and liver transplantation.
Treatment: Addressing the Underlying Cause
The most important treatment for cirrhosis is stopping or controlling the underlying cause. For alcohol-related cirrhosis, complete abstinence from alcohol is essential and can improve survival even in decompensated disease. For hepatitis B, long-term antiviral therapy suppresses the virus and reduces disease progression. For hepatitis C, curative antiviral treatment eliminates the virus and can improve fibrosis over time.
For NASH-related cirrhosis, weight loss, metabolic management, and emerging pharmacotherapies address the metabolic drivers. For autoimmune hepatitis, immunosuppressive medications control the inflammatory process. For hemochromatosis, phlebotomy removes excess iron. In every case, treating the cause — when possible — prevents further damage and gives the liver the best chance of maintaining (or even recovering) function.
Liver transplantation is the definitive treatment for end-stage cirrhosis. It offers excellent long-term survival — over 75% of transplant recipients survive at least five years. Eligibility is determined by disease severity (MELD score), absence of contraindications, and ability to adhere to post-transplant care. Over 9,000 liver transplants are performed annually in the United States, though the waitlist demand exceeds organ availability. Understanding healthcare costs is important when navigating the complex financial landscape of transplant care.
Frequently Asked Questions
Can cirrhosis be reversed?
Advanced cirrhosis with extensive scarring is generally considered irreversible. However, treating the underlying cause can halt progression and, in some cases, allow modest improvement in liver function and even regression of fibrosis. Early cirrhosis (particularly compensated) has better potential for stabilization. The liver’s regenerative capacity is remarkable, but it has limits — which is why early detection and treatment of the underlying cause are so critical.
How much alcohol causes cirrhosis?
There’s no single threshold that guarantees cirrhosis — susceptibility varies based on genetics, sex, body weight, nutrition, and concurrent liver conditions. However, risk increases significantly with consumption above two to three drinks per day for men and one to two for women over 10 or more years. Women develop cirrhosis at lower alcohol levels than men. Not all heavy drinkers develop cirrhosis, but the risk rises progressively with amount and duration.
Can you live a normal life with cirrhosis?
Many people with compensated cirrhosis live active lives for years. The key is managing the underlying cause, avoiding further liver injury (especially alcohol and hepatotoxic medications), following medical surveillance schedules, and maintaining good nutrition. Quality of life can be good in the compensated stage, though it typically declines significantly once decompensation occurs.
What should you eat with cirrhosis?
Nutrition is critical in cirrhosis. A balanced diet with adequate protein (1.0-1.5 g/kg/day for compensated cirrhosis) helps prevent muscle wasting, which is common. Sodium restriction (less than 2,000 mg daily) is important for managing ascites. Small, frequent meals — including a nighttime snack — help maintain nutrition. Avoid alcohol completely. A dietitian with experience in liver disease can create an individualized plan.
How long can you live with cirrhosis?
Survival depends heavily on the stage. Compensated cirrhosis has a median survival of 12+ years. Once decompensation occurs (ascites, variceal bleeding, encephalopathy, or jaundice), median survival drops to approximately 2 years without transplantation. MELD score and the Child-Pugh classification help estimate prognosis. Treating the underlying cause and preventing decompensation are the most impactful factors for survival.
What You Should Do Now
If you’ve been diagnosed with cirrhosis, the most important actions are to eliminate the underlying cause (stop drinking, treat hepatitis, manage metabolic risk factors), take all prescribed medications, follow a low-sodium diet, attend all surveillance appointments (including ultrasound screening for liver cancer every six months), and avoid anything that could further injure the liver — particularly alcohol and unnecessary medications.
If you have risk factors for liver disease — heavy alcohol use, chronic hepatitis B or C, obesity with metabolic syndrome, or a family history of liver disease — get screened. Blood tests and non-invasive fibrosis assessment can identify liver damage long before cirrhosis develops, when intervention is most effective. The liver gives you many chances to change course. The key is recognizing and acting on them before the damage becomes irreversible.